-21.2%
PINS vs GSK
+76.3%
-97.5%
-82.7%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.5% | -1.2% | +2.7% | +1.9% |
| 7D | -9.4% | -1.1% | -8.3% | -9.0% |
| 30D | -10.2% | +7.8% | -18.1% | -12.6% |
| 3M | -19.0% | +0.3% | -19.3% | -19.3% |
| 6M | -7.4% | +3.4% | -10.8% | -9.1% |
| YTD | -25.7% | +5.9% | -31.6% | -29.1% |
| 1Y | -29.7% | +8.2% | -37.9% | -33.6% |
| 3Y | -38.1% | +65.3% | -103.4% | -54.5% |
| 5Y | -57.3% | +43.3% | -100.6% | -66.7% |
| All | -21.2% | +76.3% | -97.5% | -44.5% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling